Atara Biotherapeutics Ownership | Who Owns Atara Biotherapeutics?
Atara Biotherapeutics Ownership Summary
Atara Biotherapeutics is owned by 19.38% institutional investors, 21.74% insiders, and 58.87% retail investors. Ifp advisors is the largest institutional shareholder, holding 0.00% of ATRA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.05% of its assets in Atara Biotherapeutics shares.
ATRA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Atara Biotherapeutics | 19.38% | 21.74% | 58.87% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ifp advisors | 4.50K | 0.00% | $1.76K |
Geode capital management | - | - | - |
Marshall wace, llp | - | - | - |
Proshare advisors | - | - | - |
Legal & general group | - | - | - |
Renaissance | - | - | - |
Voya investment management | - | - | - |
Ecor1 capital | - | - | - |
Engineers gate manager lp | - | - | - |
Price t rowe associates inc /md/ | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Ifp advisors | 4.50K | 0.00% | $1.76K |
Geode capital management | - | - | - |
Marshall wace, llp | - | - | - |
Proshare advisors | - | - | - |
Legal & general group | - | - | - |
Renaissance | - | - | - |
Voya investment management | - | - | - |
Ecor1 capital | - | - | - |
Engineers gate manager lp | - | - | - |
Price t rowe associates inc /md/ | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ifp advisors | 4.50K | 0.00% | - |
Citigroup | - | - | -2.00 |
Nelson, van denburg & campbell wealth management group | - | - | -23.00 |
Eversource wealth advisors | - | - | -35.00 |
Nisa investment advisors | - | - | -50.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | - | - | -10.17M |
Redmile group | - | - | -9.26M |
Blackrock | - | - | -6.83M |
Bank of america corp /de/ | - | - | -6.58M |
Vanguard group | - | - | -5.01M |
Sold Out
Holder | Change |
---|---|
Citigroup | -2.00 |
Nelson, van denburg & campbell wealth management group | -23.00 |
Eversource wealth advisors | -35.00 |
Nisa investment advisors | -50.00 |
Gamma investing | -56.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 36 | -14.29% | 2,086,297 | -10.96% | 19 | 4.03% | 13 | -43.48% | 13 | 18.18% |
Dec 31, 2024 | 2 | 100.00% | 63 | 80.00% | - | 360000.00% | 1 | - | - | - |
Sep 30, 2024 | 1 | -80.00% | 35 | -99.98% | - | 2.78% | - | -100.00% | - | -100.00% |
Jun 30, 2024 | 5 | -93.98% | 182,077 | -99.78% | - | 0.00% | 1 | -97.62% | 2 | -92.86% |
Mar 31, 2024 | 83 | -9.78% | 83,283,248 | 28.68% | 78 | 2.13% | 42 | -8.70% | 28 | -15.15% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 120.26K | 2.05% | - |
Vanguard US Total Market Shares ETF | 120.26K | 2.05% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 66.45K | 1.13% | - |
Fidelity Extended Market Index | 29.61K | 0.51% | 292.00 |
Fidelity VIP Disciplined Small Cap Init | 16.24K | 0.28% | 6.08K |
Bridgeway Ultra-Small Company Market | 14.00K | 0.23% | - |
Fidelity Enhanced Small Cap ETF | 10.45K | 0.18% | - |
Fidelity Total Market Index | 10.59K | 0.18% | - |
NT R2000 Value Index Fund - NL | 255.47K | 0.18% | - |
NT R2000 Index Fund - NL | 9.83K | 0.17% | -1.01K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 16, 2025 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | $15.00K |
May 16, 2025 | Nguyen AnhCo | President and CEO | Sell | $22.16K |
Mar 03, 2025 | Nguyen AnhCo | President and CEO | Sell | $23.31K |
Mar 03, 2025 | Hyllengren Eric J | EVP, CFO and COO | Sell | $8.47K |
Mar 03, 2025 | Henrich Jill | EVP, Chief Regulatory Officer | Sell | $7.41K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 2 |
2025 Q1 | - | 3 |
2024 Q4 | - | 3 |
2024 Q3 | - | 12 |
2024 Q2 | - | 5 |
ATRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools